Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease
Reexamination Certificate
2006-09-05
2006-09-05
Saidha, Tekchand (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Transferase other than ribonuclease
C435S252300, C435S320100, C435S886000, C536S023200, C530S350000
Reexamination Certificate
active
07101695
ABSTRACT:
Embodiments of the invention generally provide methods and compositions for producing recombinant transglutaminases. The purified recombinant transglutaminases of the invention are reactive to a broad range of compounds and exhibit broad substrate activity. In one embodiment,Streptoverticillium mobaraense(ATCC 29032), andStreptoverticillium cinnamoneum(ATCC 11874) recombinant transglutaminase fusion proteins purified fromE. coliare provided to a better yield, higher purity, and activity than hitherto possible by recombinant DNA technology.
REFERENCES:
patent: 5156956 (1992-10-01), Motoki et al.
patent: 5252469 (1993-10-01), Andou et al.
patent: 5420025 (1995-05-01), Takagi et al.
patent: 5726051 (1998-03-01), Fraij et al.
patent: 5827712 (1998-10-01), Yokoyama et al.
patent: 6010871 (2000-01-01), Takahara et al.
patent: 6013498 (2000-01-01), Yokoyama et al.
patent: 6013526 (2000-01-01), Takahara et al.
patent: 6030821 (2000-02-01), Soeda et al.
patent: 6100053 (2000-08-01), Bech et al.
patent: 6121013 (2000-09-01), Yamaguchi
patent: 6190879 (2001-02-01), Bech et al.
patent: 6190896 (2001-02-01), Fraij
patent: 6833258 (2004-12-01), Yokoyama et al.
patent: 0481504 (1992-04-01), None
patent: 10300889 (1989-12-01), None
patent: 4108381 (1992-04-01), None
patent: 6030771 (1994-02-01), None
patent: WO 2000/40706 (2000-07-01), None
patent: WO 2000/70026 (2000-11-01), None
patent: WO 1999/51723 (2001-04-01), None
patent: WO 2001/23591 (2001-04-01), None
patent: WO 02/14518 (2002-02-01), None
Sequence alignment between SEQ ID No.: 2 from U.S. Appl. No. 6,833,258 and Applicants' SEQ ID No.: 6.
Sequence alignment between Accession No. AAB97831 and Applicants' SEQ ID No.: 6.
Sequence alignment between Accession No. AAB97831 and Applicants' SEQ ID No.: 10.
Sequence alignment between Accession No. AAB97830 and Applicants' SEQ ID No.: 8; & Sequence alignment between Accession No. AAB97830 and Applicants' SEQ ID No.: 12.
Gordon Ada, D.Sc., Vaccines and Vaccination. N Engl J Med, vol. 345, No. 14, p. 1042-1053.
Brandt ER, Sriprakash KS, Hobb RI, et al. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian aboriginal population. Nat. Med. 2000-6-455-9.
Nardin EH, Oliveira GA, Calvo-Calle JM, et al. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccines of defined HLA genotypes. J Infect Dis 2000;182:1486-96.
Watanabe et. al. Efficacy of chemically cross-linked antigens for accelular pertussis vaccine. Vaccine 19, 1199-1203 (2001).
Nancy St. Clair et. al. Cross-linked protein crystals for vaccine delivery. Proc. Natl. Acad. Sci. USA, vol. 96, pp. 9469-9474, Aug. 1999.
Raghunath et al., “Cross-Linking of the Dermo-Epidermal Junction of Skin Regenerating from Keratinocyte Autografts”, J. Clin. Invest., vol. 98, No. 5, pp. 1174-1184, 1996.No.:05 Recombinant SC transglutaminase N-terminal sequence.
Jurgennsen et al., “A New Biological Glue for Cartilage-Cartilage Interfaces: Tissue Transglutaminase”, The Journal of Bone and Joint Surgery, Inc., vol. 79-A, No. 2, Feb. 1997.
de Jong et al: “Purification and Substrate Specificity of Transglutaminases from Blood and Streptoverticillium mobaraense” Journal of Agricultural Food Chemistry 2001, vol. 49, pp. 3389-3393.
Washizu et al., “Molecular cloning of the gene for microbial transglutaminase from streptoverticillium and its expression in Streptomyces lividans” Biosci Biotech, Biochem, vol. 58 No. 1, pp. 82-87 (1994).
Pasternack et al., “Bacterial Pro-Transglutaminase from Streptoverticillium Mobaraense Purification, Characterisation and Sequence of the Zymogen” Euo. J. Biochem 1998, vol. 257, pp. 570-576.
Liu et al., “Effect of Transglutaminase-Catalyzed Polymerization of its Emulsifying Properties” Journal of Agricultural Food Chemistry 1999, vol. 47, pp. 1514-1519.
Duran et al., “Purification, Characterisation, and Gene Cloning of Transglutaminase from Streptoverticillium Cinnamoneum CBS 683.68” Biochimie 80 (4) 1998, pp. 313-319.
Kahlem et al., “Peptides Containing Glutamine Repeats as Substrates for Transglutaminase-Catalyzed Cross-Linking: Relevance to Diseases of the Nervous System” Proc. National Academy of Science USA, vol. 93, pp. 14580-14585, Dec. 1996. Cell Biolog.
O'Brien-Simpson et al., “Polymerization of Unprotected Synthetic Peptides: A View toward Synthetic Peptides Vaccines” Journal of American Chemistry Society, 1997, vol. 119, pp. 1183-1188.
Jackson et al., “Free Radical Induced Polymerization of synthetic peptides into polymeric immunogens” Vaccine, vol 15, No. 15, pp. 1697-1705, 1997.
Kanaji et al., “Primary structure of microbial transglutaminase from Streptoverticillium” J. Biol. Chem. 268, 11565-11572, 1994.
Folk, J. E., and Cole, P.W. Mechanism of action of guinea pig liver transglutaminase. I. Purification and properties of the enzyme: identification of a functional cysteine essential for activity. J Biol Chem. Dec. 10, 1966;241(23):5518-25.
Shi, Q. et al. Expression inEscherichia coliand Purification of Hexahistidine-Tagged Human Tissue Transglutaminase. Protein Expr Purif. Apr. 2002;24(3):366-73.
Natsuka, S. et al. Molecular cloning and expression of Caenorhabditis elegans ERp57-homologue with transglutaminase activity. J Biochem (Tokyo). Dec. 2001;130(6):731-5.
Shcmidt et al. Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin. Infection and Immunity Dec. 2001;69(12):7663-70.
Sato, H. et al. “Further studies on the site-specific protein modification by microbial transglutaminase.” Bioconjug Chem. Sep.-Oct. 2001;12(5):701-10.
Suzuki, S. et al. Purification and characterization of novel transglutaminase fromBacillus subtilisspores. Biosci Biotechnol Biochem. Nov. 2000;64(11):2344-51.
Rucker, E. et al. Rapid evaluation and optimization of recombinant protein production using GFP tagging. Protein Expr Purif. Feb. 2001;21(1):220-3.
Eli-Berchoer, L. et al. Effect of intramolecular cross-linking between glutamine-41 and lysine-50 on actin structure and function. J Muscle Res Cell Motil. 2000;21(5):405-14.
Clemente, MG et al. Immune reaction against the cytoskeleton in coeliac disease. Gut. Oct. 2000;47(4):520-6.
Taguchi, S. et al. Substrate specificity analysis of microbial transglutaminase using proteinaceous protease inhibitors as natural model substrates. J Biochem (Tokyo). Sep. 2000;128(3):415-25.
Suzuki, Y. et al. Localization of porcine trappin-2 (SKALP/elafin) in trachea and large intestine by in situ hybridization and immunohistochemistry. Histochem Cell Biol. Jul. 2000;114(1):15-20.
Yamaguchi, S. et al. A novel protein-deamidating enzyme from Chryseobacterium proteolyticum sp. nov., a newly isolated bacterium from soil. Appl Environ Microbiol. Aug. 2000;66(8):3337-43.
Yokoyama, KI et al. Overproduction of microbial transglutaminase inEscherichia coli, in vitro refolding, and characterization of the refolded form. Biosci Biotechnol Biochem. Jun. 2000;64(6):1263-70.
Bechtold, U. et al. Enzymic preparation of protein G-peroxidase conjugates catalysed by transglutaminase. J Biochem (Tokyo). Feb. 2000;127(2):239-45.
Schmidt, G. et al. Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for rho GTPases. J Biol Chem. Nov. 5, 1999;274(45):31875-81.
Yokoyama, K. et al. Overproduction of DnaJ inEscherichia coliimproves in vivo solubility of the recombinant fish-derived transglutaminase. Biosci Biotechnol Biochem. Jun. 1998;62(6):1205-10.
Makarova, K. et al. A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases. Protein Sci. Aug. 1999;8(8):1714-9.
Kobayashi, K. et al. Molecular cloning of the transglutaminase gene fromBacillus subtilisand its expression inEscherichia coli. Biosci Biotechnol Biochem. Jun. 1998;62(6):1109-14.
Pasternack et al. A fluorescent substrate of transglutaminase for detection and characterization of glutamine acceptor compounds. Anal Bi
Chen Ya-Fen
Patterson & Sheridan LLP
Saidha Tekchand
LandOfFree
Method of producing transglutaminase having broad substrate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of producing transglutaminase having broad substrate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing transglutaminase having broad substrate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3566094